Preferred Label : insulin glulisine;

MeSH note : provides greater beta-cell protective action;

MeSH synonym : insulin, lysyl(B3)-glutamyl(B29)-; insulin, Lys(B3)-Glu(B29)-; glulisine insulin; B3-lysyl-B29-glutamylinsulin;

MeSH Related Number : 207748-29-6 (insulin glulisine);

Registry Number MeSH : 207748-29-6;

Is substance : O;

UNII : 7XIY785AZD;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_2609229/fr/apidra
2016
true
France
French
diabetes mellitus
insulin glulisine
hypoglycemic agents
insulin glulisine
insurance, health, reimbursement
adult
adolescent
child
injections, subcutaneous
insulin, Short-Acting
insulin
evaluation of the transparency committee

---
https://www.ema.europa.eu/medicines/human/EPAR/Apidra
2011
United Kingdom
English
French
syndication feed
diabetes mellitus
hypoglycemic agents
hypoglycemic agents
insulin
insulin glulisine
insulin glulisine
insulin glulisine
insulin, Short-Acting
insulin, Short-Acting
injections, subcutaneous
drug approval
treatment outcome
drug evaluation
package leaflet
summary of product characteristics

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00008
2011
false
false
false
Canada
drug information
insulin
insulin glulisine
insulin glulisine

---
http://www.has-sante.fr/portail/jcms/c_987177/apidra
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/apidra_-_ct-8579.pdf
2010
France
French
insulin glulisine
hypoglycemic agents
insulin glulisine
insurance, health, reimbursement
adult
adolescent
child
injections, subcutaneous
insulin, Short-Acting
insulin
evaluation of the transparency committee

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Apidra_February-19-2009_f.pdf
2009
Canada
French
insulin, Short-Acting
insulin
treatment outcome
insulin glulisine
canada
insurance, health, reimbursement
hypoglycemic agents
adult
randomized controlled trials as topic
diabetes mellitus
Glycated Hemoglobin
injections, subcutaneous
insulin glulisine
drug evaluation

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.